Home Markets InflaRx stock soars after positive Phase 2a data for INF904 drug

InflaRx stock soars after positive Phase 2a data for INF904 drug

Nov 10, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/inflarx-stock-soars-after-positive-phase-2a-data-for-inf904-drug-93CH-4345710

You May Also Like

US says BYD, Baidu, Alibaba and other tech giants are aiding China’s military

WhiteHawk Minerals prices upsized IPO at $26 per share

OpenAI files for US IPO after Anthropic as AI giants head to public markets

Salesforce to acquire m3ter for consumption billing expansion

Intesa launches $35 billion Monte dei Paschi bid to redraw Italy’s financial map

AstraZeneca obesity pill shows 10.5% weight loss in trial